Novo Nordisk (NVO.US) and Ypsomed Enter Long-Term Supply Agreement for Autoinjectors

Intelligent Finance APP learned that Novo Nordisk (NVO.US) signed a long-term agreement with Ypsomed Holding AG for the supply of auto-injectors. In a statement released on Wednesday, Ypsomed Holding AG stated that the company is increasing its production capacity for large quantities of auto-injectors.

Novo Nordisk Becomes Europe's Most Valuable Company Due to Wegovy, Faces Demand Exceeding Production Capacity